论文部分内容阅读
目的 :比较头孢吡肟和头孢他啶治疗中、重度肺炎的疗效及费用。方法 :中、重度肺炎病人随机分为 2组 ,2 8例 (男性 2 6例 ,女性 2例 ;年龄 79a±s 6a)予头孢吡肟 1.0 g ,iv ,gtt ,bid。 2 8例 (男性 2 5例 ,女性 3例 ;年龄 78a± 4a)予头孢他啶 1.0 g ,iv ,gtt,q 8h。 2组均以 7～ 10d为一个疗程。结果 :2组临床有效率分别为 96 %和 93% (P >0 .0 5)。总医疗费用头孢他啶组较头孢吡肟组高 ,分别为 6 92 4元± 70 2元和 550 4元± 6 15元。结论 :2组疗效相同 ,费用有显著差异 ,头孢他啶组总医疗费用高。
Objective: To compare the efficacy and cost of cefepime and ceftazidime in the treatment of moderate and severe pneumonia. Methods: The patients with moderate and severe pneumonia were randomly divided into 2 groups, 28 cases (26 males and 2 females; age 79a ± s 6a) received cefepime 1.0 g, iv, gtt, bid. 28 (male 25, female 3; age 78a ± 4a) were given ceftazidime 1.0 g, iv, gtt, q 8h. 2 groups were 7 ~ 10d for a course of treatment. Results: The clinical effective rates in the two groups were 96% and 93%, respectively (P> 0.05). The total medical cost of ceftazidime group was higher than that of cefepime group, which were respectively 6 92 4 yuan ± 70 2 yuan and 550 4 yuan ± 6 15 yuan. Conclusion: The two groups of the same effect, the cost was significantly different, ceftazidime total cost of treatment.